CELIA
OREJA GUEVARA
Profesora asociada de Ciencias de la Salud
Karolinska Institute
Estocolmo, SueciaPublikationen in Zusammenarbeit mit Forschern von Karolinska Institute (4)
2023
-
Predictors of treatment switching in the Big Multiple Sclerosis Data Network
Frontiers in Neurology, Vol. 14
2022
-
Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data
Multiple Sclerosis Journal, Vol. 28, Núm. 5, pp. 842-846
2017
-
Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis Experts
CNS Drugs, Vol. 31, Núm. 1, pp. 33-50
-
Towards personalized therapy for multiple sclerosis: Prediction of individual treatment response
Brain, Vol. 140, Núm. 9, pp. 2426-2443